Ergoteles LLC - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 125 filers reported holding ZIOPHARM ONCOLOGY INC in Q4 2022. The put-call ratio across all filers is 0.04 and the average weighting 0.0%.

Quarter-by-quarter ownership
Ergoteles LLC ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q4 2022$74,082
-91.1%
114,131
-76.5%
0.00%
-89.7%
Q3 2022$835,000
-28.1%
485,434
-48.2%
0.03%
-17.1%
Q2 2022$1,162,000
+198.7%
936,900
+337.8%
0.04%
+150.0%
Q3 2021$389,000
+221.5%
214,000
+367.2%
0.01%
+366.7%
Q2 2021$121,000
+181.4%
45,800
+166.3%
0.00%
-50.0%
Q3 2020$43,00017,2000.01%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q4 2022
NameSharesValueWeighting ↓
Third Security, LLC 17,815,708$47,033,0002.93%
Essex Woodlands Management, Inc. 2,764,908$7,130,0002.60%
Belmont Global Advisors, Inc. 973,000$2,569,0002.01%
Belmont Global Advisors, Inc. 135,700$358,0000.28%
MSD Partners, L.P. 2,750,000$7,260,0000.22%
SFMG, LLC 99,850$264,0000.08%
Rotella Capital Management, Inc. 11,090$29,0000.03%
WESTPORT RESOURCES MANAGEMENT INC 33,500$88,0000.02%
SMITH ASSET MANAGEMENT GROUP LP 236,590$625,0000.02%
FRANKLIN STREET ADVISORS INC /NC 41,150$109,0000.02%
View complete list of ZIOPHARM ONCOLOGY INC shareholders